Application 202467

Type
ANDA
Sponsor
MACLEODS PHARMS LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001PIOGLITAZONE HYDROCHLORIDEPIOGLITAZONE HYDROCHLORIDETABLET;ORALEQ 15MG BASENoNo
002PIOGLITAZONE HYDROCHLORIDEPIOGLITAZONE HYDROCHLORIDETABLET;ORALEQ 30MG BASENoNo
003PIOGLITAZONE HYDROCHLORIDEPIOGLITAZONE HYDROCHLORIDETABLET;ORALEQ 45MG BASENoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
16714-645PioglitazonePioglitazoneNorthStar RxLLCANDACurrent
16714-645PioglitazonePioglitazoneNorthStar RxLLCANDACurrent
16714-646PioglitazonePioglitazoneNorthStar RxLLCANDACurrent
16714-646PioglitazonePioglitazoneNorthStar RxLLCANDACurrent
16714-647PioglitazonePioglitazoneNorthStar RxLLCANDACurrent
16714-647PioglitazonePioglitazoneNorthStar RxLLCANDACurrent
33342-054PioglitazonePioglitazoneMacleods Pharmaceuticals LimitedANDACurrent
33342-054PioglitazonePioglitazoneMacleods Pharmaceuticals LimitedANDACurrent
33342-054PioglitazonePioglitazoneMacleods Pharmaceuticals LimitedANDACurrent
33342-055PioglitazonePioglitazoneMacleods Pharmaceuticals LimitedANDACurrent
33342-055PioglitazonePioglitazoneMacleods Pharmaceuticals LimitedANDACurrent
33342-055PioglitazonePioglitazoneMacleods Pharmaceuticals LimitedANDACurrent
33342-056PioglitazonePioglitazoneMacleods Pharmaceuticals LimitedANDACurrent
33342-056PioglitazonePioglitazoneMacleods Pharmaceuticals LimitedANDACurrent
33342-056PioglitazonePioglitazoneMacleods Pharmaceuticals LimitedANDACurrent
50090-2637PioglitazonePioglitazoneA-S Medication SolutionsANDACurrent
68071-2264PioglitazonePioglitazoneNuCare Pharmaceuticals,Inc.ANDACurrent
68071-2264PioglitazonePioglitazoneNuCare Pharmaceuticals,Inc.ANDACurrent
71335-0088PioglitazonePioglitazoneBryant Ranch PrepackANDACurrent
71335-0088PioglitazonePioglitazoneBryant Ranch PrepackANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
10056ORIG2013-02-08